Lynx Signs, Renews Contracts for MPSS Gene Expression Service

May 13, 2004

This story has been updated from a previous version.

NEW YORK, May 13 (GenomeWeb News) - Lynx Therapeutics has signed three new contracts and renewed two others for its Massively Parallel Signature Sequencing gene expression analysis service, the company said today.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Not a Unique Challenge Anymore

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Case Goes On

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

The Very Old, Very Young, and Very Talented

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

This Week in PLOS

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.

Main menu